Finance

Lists
ASIX:BMV
AdvanSix Inc
MX$273.00
0.00%
(0.00) 1D
Aug 10, 8:13:00 AM GMT-6  ·   MXN
All symbols
SymbolPriceChange% Change
Generating top insights for ASIX...
Mkt. cap
439.04M
Avg. vol.
6.00
Volume
0.00
52-wk high
MX$517.45
52-wk low
MX$273.00
Shares outstanding
29.80M
No. of employees
1K
Mkt. cap
439.04M
Avg. vol.
6.00
Volume
0.00
52-wk high
MX$517.45
52-wk low
MX$273.00
Shares outstanding
29.80M
No. of employees
1K
Profile
AdvanSix Inc. is an American chemical company that produces nylon 6 and related chemicals such as caprolactam and ammonium sulfate fertilizers. It operated as Honeywell's Resins and Chemicals division until 2016, when it was spun off as a separate company. The unit accounted for 3 percent of Honeywell's sales at the time. For 2019, revenue is estimated at $1.4 billion. The company traces its lineage to the H. W. Jayne Company, established 1884 in Frankford, Pennsylvania. AdvanSix has plants in Chesterfield and Hopewell, Virginia, and Frankford and Pottsville, Pennsylvania. The Hopewell plant is one of the world's largest single-site producers of caprolactam. It has an annual production capacity of 600,000 tons of ammonia and 400,000 tons of caprolactam. For context, global annual demand for caprolactam is estimated at 5 million tons. AdvanSix is an integrated chemical manufacturer. It produces phenol in Frankford through the cumene process, where it is converted to caprolactam in Hopewell, polymerized to nylon 6 in Chesterfield and made into film at Pottsville. In addition to internal use, AdvanSix sells acetone, phenol, and alpha-methylstyrene from the cumene process. Wikipedia
About AdvanSix Inc
CEO-
Employees1.41K
Founded2016
HeadquartersParsippany-Troy Hills, New Jersey, United States
SectorCommodity chemical
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
374.47M
359.95M
404.18M
421.28M
Cost of goods sold
349.09M
332.58M
400.38M
390.18M
Cost of revenue
349.09M
332.58M
400.38M
390.18M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
27.42M
28.50M
22.52M
22.05M
Operating expense
27.42M
28.50M
22.52M
22.05M
Total operating expenses
376.51M
361.08M
422.90M
412.24M
Operating income
-2.04M
-1.13M
-18.72M
9.05M
Other non operating income
815.00K
891.00K
469.00K
215.00K
EBT including unusual items
-3.55M
-2.60M
-20.68M
6.65M
EBT excluding unusual items
-3.55M
-2.60M
-20.68M
6.65M
Income tax expense
-909.00K
190.00K
-5.13M
3.41M
Effective tax rate
25.63%
-7.30%
24.82%
51.19%
Other operating expenses
-
-
-
-
Net income
-2.64M
-2.79M
-15.55M
3.25M
Net profit margin
-0.70%
-0.78%
-3.85%
0.77%
Earnings per share
0.08
0.03
-0.50
0.19
Interest and investment income
-
-
-
-
Interest expense
-2.32M
-2.36M
-2.43M
-2.61M
Net interest expenses
-2.32M
-2.36M
-2.43M
-2.61M
Depreciation and amortization charges
-
-
-
-
EBITDA
18.29M
19.64M
2.24M
29.84M
Gain or loss from assets sale
-
96.00K
4.00K
130.00K
AI content may include mistakes. Learn more
AI content may include mistakes. Learn more
Google apps